Diamantstein T[au] - Search Results

Year	Number of Results
1959	1
1961	1
1962	1
1964	3
1965	2
1966	1
1967	1
1968	1
1969	4
1970	3
1971	8
1973	7
1974	4
1975	7
1976	4
1977	2
1978	4
1979	7
1980	5
1981	7
1982	3
1983	2
1984	6
1985	16
1986	20
1987	28
1988	20
1989	26
1990	21
1991	14
1992	7
1993	9
1994	6
1995	2
1996	4
1998	1
2022	0

1

Interleukin 2 receptor--a target for immunosuppressive therapy.

Diamantstein T, Osawa H, Kirkman RL, Shapiro ME, Strom TB, Tilney NL, Kupiec-Weglinski JW. Diamantstein T, et al. Transplant Rev (Orlando). 1987;1:177-96. doi: 10.1016/s0955-470x(87)80011-3. Transplant Rev (Orlando). 1987. PMID: 3131931 Review. No abstract available.

2

Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy.

Hock H, Dorsch M, Richter G, Kunzendorf U, Krüger-Krasagakes S, Blankenstein T, Qin Z, Diamantstein T. Hock H, et al. Among authors: diamantstein t. Nat Immun. 1994 Mar-Jun;13(2-3):85-92. Nat Immun. 1994. PMID: 8173239 Review.

3

T cells bind to the endothelial adhesion molecule GMP-140 (P-selectin).

Kunzendorf U, Notter M, Hock H, Distler A, Diamantstein T, Walz G. Kunzendorf U, et al. Among authors: diamantstein t. Transplantation. 1993 Nov;56(5):1213-7. doi: 10.1097/00007890-199311000-00031. Transplantation. 1993. PMID: 7504345

4

Differential requirement for accessory cells in polyclonal T-cell activation.

Sopori ML, Hurt YL, Cherian S, Kaplan AM, Diamantstein T. Sopori ML, et al. Among authors: diamantstein t. Cell Immunol. 1987 Mar;105(1):174-86. doi: 10.1016/0008-8749(87)90066-9. Cell Immunol. 1987. PMID: 3028651

5

The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies.

Diamantstein T, Osawa H. Diamantstein T, et al. Immunol Rev. 1986 Aug;92:5-27. doi: 10.1111/j.1600-065x.1986.tb01491.x. Immunol Rev. 1986. PMID: 3091483 Review.

6

Interleukin-2 receptor-targeted immune therapy.

Diamantstein T, Hahn HJ. Diamantstein T, et al. Immunol Ser. 1993;59:295-318. Immunol Ser. 1993. PMID: 8461395 Review. No abstract available.

7

IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.

Volk HD, Diamantstein T. Volk HD, et al. Among authors: diamantstein t. Clin Exp Immunol. 1986 Dec;66(3):525-31. Clin Exp Immunol. 1986. PMID: 2952381 Free PMC article.

8

"Self-reactive" T cells. III. In vitro restimulation of T cells, "responding" in vivo or in vitro to syngeneic lymphoid cells.

Reimann J, Diamantstein T. Reimann J, et al. Among authors: diamantstein t. Immunobiology. 1980 Dec;157(4-5):463-73. doi: 10.1016/S0171-2985(80)80015-5. Immunobiology. 1980. PMID: 6450160

9

Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation.

Kupiec-Weglinski JW, Diamantstein T, Tilney NL. Kupiec-Weglinski JW, et al. Among authors: diamantstein t. Transplantation. 1988 Dec;46(6):785-92. doi: 10.1097/00007890-198812000-00001. Transplantation. 1988. PMID: 2462756 Review.

10

Nonspecific "lymphocyte activating" factors produced by macrophages.

Diamantstein T, Oppenheim JJ, Unanue ER, Wood DD, Handschumacher RE, Rosenstreich DL, Waksman BH. Diamantstein T, et al. Clin Immunol Immunopathol. 1979 Oct;14(2):264-7. doi: 10.1016/0090-1229(79)90149-1. Clin Immunol Immunopathol. 1979. PMID: 226303 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results